Terms: = Ovarian cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
13 results:
1. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
2. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing dnmt3a-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line.
Yen HY; Tsao CW; Lin YW; Kuo CC; Tsao CH; Liu CY
Sci Rep; 2019 Nov; 9(1):17267. PubMed ID: 31754130
[TBL] [Abstract] [Full Text] [Related]
4. miR-145 promotes miR-133b expression through c-myc and dnmt3a-mediated methylation in ovarian cancer cells.
Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
[TBL] [Abstract] [Full Text] [Related]
5. Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.
Nteliopoulos G; Bazeos A; Claudiani S; Gerrard G; Curry E; Szydlo R; Alikian M; Foong HE; Nikolakopoulou Z; Loaiza S; Khorashad JS; Milojkovic D; Perrotti D; Gale RP; Foroni L; Apperley JF
Haematologica; 2019 Dec; 104(12):2400-2409. PubMed ID: 31073075
[TBL] [Abstract] [Full Text] [Related]
6. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract] [Full Text] [Related]
7. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells.
Zhang S; Pei M; Li Z; Li H; Liu Y; Li J
Cancer Sci; 2018 Sep; 109(9):2734-2745. PubMed ID: 29993160
[TBL] [Abstract] [Full Text] [Related]
8. A Double-Negative Feedback Interaction between MicroRNA-29b and dnmt3a/3B Contributes to ovarian cancer Progression.
Teng Y; Zuo X; Hou M; Zhang Y; Li C; Luo W; Li X
Cell Physiol Biochem; 2016; 39(6):2341-2352. PubMed ID: 27832631
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of dnmt3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response.
Lu W; Lu T; Wei X
Oncol Rep; 2016 Dec; 36(6):3597-3604. PubMed ID: 27748882
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract] [Full Text] [Related]
11. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Br J Cancer; 2013 Feb; 108(3):579-86. PubMed ID: 23370212
[TBL] [Abstract] [Full Text] [Related]
12. Live-attenuated measles virus vaccine confers cell contact loss and apoptosis of ovarian cancer cells via ROS-induced silencing of E-cadherin by methylation.
Zhou S; Li Y; Huang F; Zhang B; Yi T; Li Z; Luo H; He X; Zhong Q; Bian C; Lin X; Qi X; Liu P; Huang C; Zhao X; Wei Y
Cancer Lett; 2012 May; 318(1):14-25. PubMed ID: 22269942
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract] [Full Text] [Related]